IMOS vs KDK

Despite a strong Piotroski F-Score of 7/9 indicating solid operational health, IMOS is severely overvalued with a current price of $40.91 far exceeding its Graham Number ($14.41) and Intrinsic Value ($12.69). While the company shows impressive earnings growth (126.8% YoY), its profitability is precarious with a razor-thin profit margin of 2.07%. Most concerning is the unsustainable dividend payout ratio of 176.43%, suggesting the dividend is funded by capital or debt rather than earnings. The combination of a bearish technical trend (10/100) and extreme valuation multiples makes the current entry point high-risk.

KDK exhibits severe financial distress, highlighted by a Piotroski F-Score of 1/9, indicating critical weakness in fundamental health. The company is operating with negative equity (Price/Book of -4.74) and an astronomical Price/Sales ratio of 364.61, suggesting extreme overvaluation relative to its current revenue generation. Revenue has collapsed by 92.30% YoY, and operating margins are deeply negative at -3676.16%. While analysts maintain a 'strong_buy' rating with a target of $15.70, this is completely decoupled from the deterministic financial data and current bearish technical trend.